Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Cantor Fitzgerald
Merck
Baxter
Moodys
Cipla
McKesson
Farmers Insurance
Medtronic
Harvard Business School

Generated: February 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,133,260

« Back to Dashboard

Summary for Patent: 6,133,260
Title: Use of 7-(2-oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for the treatment of Helicobacter pylori infections and associated gastroduodenal diseases
Abstract:The invention relates to the use of quinolone- and naphthyridonecarboxylic acid derivatives which are substituted in the 7-position by a 2-oxa-5,8-diazabicyclo[4.3.0]-non-8-yl) radical, and their pharmaceutically utilizable hydrates and/or salts for the therapy of Helicobacter pylori infections and the gastroduodenal disorders associated therewith.
Inventor(s): Matzke; Michael (Wuppertal, DE), Petersen; Uwe (Leverkusen, DE), Jaetsch; Thomas (Koln, DE), Bartel; Stephan (Kurten, DE), Schenke; Thomas (Bergisch Gladbach, DE), Himmler; Thomas (Odenthal-Globusch, DE), Baasner; Bernd (Bergisch Gladbach, DE), Werling; Hans-Otto (Wuppertal, DE), Schaller; Klaus (Wuppertal, DE), Labischinski; Harald (Wuppertal, DE)
Assignee: Bayer Aktiengesellschaft (Leverkusen, DE)
Application Number:09/319,888
Patent Claim Types:
see list of patent claims
Compound; Composition; Use;

Drugs Protected by US Patent 6,133,260

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,133,260

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany196 52 239Dec 16, 1996
PCT Information
PCT FiledDecember 04, 1997PCT Application Number:PCT/EP97/06781
PCT Publication Date:June 25, 1998PCT Publication Number: WO98/26779

International Patents Family Members for US Patent 6,133,260

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
New Zealand 336228 ➤ Sign Up
Norway 325617 ➤ Sign Up
Norway 992903 ➤ Sign Up
Japan 2009235106 ➤ Sign Up
Japan 5112395 ➤ Sign Up
Japan 4463380 ➤ Sign Up
Japan 2000351781 ➤ Sign Up
Japan 3463939 ➤ Sign Up
Israel 130311 ➤ Sign Up
Japan 2000514825 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Federal Trade Commission
Farmers Insurance
Mallinckrodt
US Army
Teva
Fuji
Express Scripts
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot